medisourceasia.com

Industry News


About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

Spurious drugs bill to be moved in next session of parliament

The Union health ministry will put on fast track the much delayed Drugs and Cosmetics (Amendment) Bill, 2005, stipulating stricter penalties for manufacturing and selling spurious drugs and will move the bill in the forthcoming monsoon session of Parliament. The bill has recently received the Union Cabinet's nod.

Sources said the Union health minister Dr Anbumani Ramadoss is keen to operationalise the bill during the term of this government itself. With political equations changing fast in the national capital, the minister is learnt to be keen on the smooth passage of the bill to ensure harsh punishment to those who resort to manufacture and sell spurious drugs in the country.

Once the ministry gets the Parliament nod, it will issue a draft notification asking the general public for suggestions and objections, if any, on the proposal. After the expiry of this period, the ministry will act on the draft as per the suggestions and objections before implementing the bill.

The proposed amendment is a landmark move as it stipulates that those caught manufacturing and selling spurious drugs which are likely 'to cause death or harm to the body as would amount to serious hurt, solely on account of such a drug being administered' shall be punishable for a term which shall not be less than 10 years but may extend to imprisonment for life.

The guilty will also be liable to pay a fine which shall not be less than Rs 10 lakh or three times the value of the drugs confiscated, whichever is more. At present, the jail term for those involved in manufacturing and marketing spurious drugs is five years with a fine of Rs 10,000, which usually goes into the state's coffer. As per the new amendment, the fine paid by those found guilty of producing and selling spurious drugs would go to the family of the person who died after consuming the drug and not to the government.

Apart from specifying the relatives who will receive the compensation, the bill also incorporates a provision for creating special courts to undertake speedy trial of drug-related offences. It makes all drug-related offences cognisable and non-bailable.

(Ref: Chronicle Pharmabiz dated 25 July 2008)

Dr Batra's launches first tele-homeopathic clinic at Mumbai

Dr Batra's Positive Health Clinic Pvt Ltd (DBPHCPL), the Mumbai-based homeopathic healthcare corporate, has launched tele-homeopathic clinic to connect its 25 clinics throughout 16 major cities in the country in Mumbai. The company claims that the clinic is the first tele-homeopathic facility in the world.

The tele-homeopathic clinic would provide medical consultation and data through an easily accessible telecommunication network to offer better treatment to the patients of Dr Batra's clinics and will enable connectivity between the patient, consulting doctor and specialist through interactive video conferencing with critical information and reports through online, according to Dr Mukesh Batra, chairman and managing director of DBPHCPL.

The tele-homeopathy facility is launched in the new multi speciality clinic at Mumbai and has currently connectivity to 25 clinics in various parts of the country. The company is planning to expand the facility to all its 55 clinics within the current financial year, added Dr Batra. "By introducing tele-homeopathy we ensure patients get the finest medical aid that is both time and cost effective," he said.

The company is planning to set up 10 more clinics in cities including Bangalore and Goa freshly in this financial year. Apart, as the part of its international operations, the DBPHCPL will set up clinics at Muscat within a month. "Each of these clinics is estimated to come up with an investment of Rs 16 lakhs. In Muscat, we are opening clinics through a joint venture with Lama Polyclinic. We have also launched our company at London and the operations will start in the city soon," said Dr Batra about the overseas plans.

The company is one of the few clinics having a customized patient database which contains the patient's medical history and treatment details. The information from the database is accessible from any branch of the company through out the country. Earlier, the company also launched its cyber clinic to offer online consultation and treatment to more than 4.5 lakh people from over 86 countries every month.

(Ref: Chronicle Pharmabiz dated 24 July 2008)


Next
 

Other News

Gujarat To Bolster Healthcare Sector
CII To Organize Seminars On Regulation On Medical Devices
Conference Theme For Next Delhi IPC: “Regulation For Better Healthcare”
B Braun Launches Coroflex Please Drug Eluting Stent In India
HLL, IL&FS Ink Mou For An Integrated Medical Devices And Diagnostic Manufacturing Park
Govt. To Finance Center Of Excellence For Medical Textiles
Kehlescope, A Tongue Depressor For Examining The Oral Cavity, Invented By Indian Doctors
Productivity Council finds 40% SSI units shut due to enforcement of GMP norms
US FDA to establish offices in Delhi, Mumbai, Hyderabad soon
Centre allots Rs 630 cr for medicinal plants cultivation covering one lakh hectares
DCGI warns illegal units making medical devices, directs to obtain licenses
DCGI to establish multi-level complaint redressal system to address industry grievances
GE Sensing develops Labwatch monitoring system for pharma-biotech sector
CCE Software develops two new solutions for Pharma ERP and Medical Rep Management
Welch Allyn launches FlexiPort blood pressure cuffs
US FDA revises communication regulation to drug companies on applications

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next